Gaucher disease epidemiology and natural history: a comprehensive review of the literature
- PMID: 27762169
- DOI: 10.1080/10245332.2016.1240391
Gaucher disease epidemiology and natural history: a comprehensive review of the literature
Abstract
Objectives: The objectives of this research were: (1) to heighten awareness of Gaucher disease (GD), a rare lysosomal storage disorder with highly heterogeneous patterns of organ involvement and disease severity, to clinicians most likely to encounter these patients, and; (2) to summarize the published evidence on GD epidemiology which is essential to accurately depict the total societal burden of this rare worldwide disorder.
Methods: A comprehensive literature review was undertaken to summarize the published evidence on the epidemiology of GD. MEDLINE, EMBASE, CENTRAL, and 'grey' literature sources published in English between January 1990 and March 2015 were searched to identify relevant publications.
Results: In total, 188 full-text articles were reviewed and findings from 49 studies are summarized herein. The standardized birth incidence of GD in the general population varied from 0.39 to 5.80 per 100 000, and prevalence ranged from 0.70 to 1.75 per 100 000, respectively. Time from onset of GD symptoms to clinical diagnosis was highly variable, with median delays of up to 7 years reported.
Discussion: The incidence and prevalence of GD is substantially higher among the Ashkenazi Jewish population than the general population. Limited epidemiologic information was available from Latin America, Africa, Asia, and developed nations such as the United States, Germany, and the United Kingdom.
Conclusions: Signs and symptoms of GD frequently mimic more common hematologic conditions resulting in missed or delayed diagnosis. Early diagnosis and prompt initiation of treatment when indicated is crucial to prevent or minimize life-altering or life-threatening liver and skeletal complications.
Keywords: Gaucher disease; epidemiology; incidence; lysosomal storage disorder; mortality; natural history; prevalence; review.
Similar articles
-
Global Epidemiology of Gaucher Disease: an Updated Systematic Review and Meta-analysis.J Pediatr Hematol Oncol. 2023 May 1;45(4):181-188. doi: 10.1097/MPH.0000000000002506. Epub 2022 Jul 22. J Pediatr Hematol Oncol. 2023. PMID: 35867706 Free PMC article.
-
Disease state awareness in Gaucher disease: a Q&A expert roundtable discussion.Clin Adv Hematol Oncol. 2012 Jun;10(6 Suppl 8):1-16. Clin Adv Hematol Oncol. 2012. PMID: 22895100
-
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative.Intern Med J. 2019 May;49(5):578-591. doi: 10.1111/imj.14156. Intern Med J. 2019. PMID: 30414226 Free PMC article. Review.
-
Velaglucerase alfa for the management of type 1 Gaucher disease.Clin Ther. 2012 Feb;34(2):259-71. doi: 10.1016/j.clinthera.2011.12.017. Epub 2012 Jan 20. Clin Ther. 2012. PMID: 22264444 Review.
-
Increased incidence of cancer in adult Gaucher disease in Western Europe.Blood Cells Mol Dis. 2006 Jan-Feb;36(1):53-8. doi: 10.1016/j.bcmd.2005.08.004. Epub 2005 Oct 24. Blood Cells Mol Dis. 2006. PMID: 16246599
Cited by
-
Lipids as Emerging Biomarkers in Neurodegenerative Diseases.Int J Mol Sci. 2023 Dec 21;25(1):131. doi: 10.3390/ijms25010131. Int J Mol Sci. 2023. PMID: 38203300 Free PMC article. Review.
-
Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan.Orphanet J Rare Dis. 2024 Jan 5;19(1):11. doi: 10.1186/s13023-023-02996-9. Orphanet J Rare Dis. 2024. PMID: 38183145 Free PMC article.
-
Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project.Orphanet J Rare Dis. 2023 Dec 15;18(1):390. doi: 10.1186/s13023-023-02939-4. Orphanet J Rare Dis. 2023. PMID: 38102667 Free PMC article.
-
Noninvasive DBS-Based Approaches to Assist Clinical Diagnosis and Treatment Monitoring of Gaucher Disease.Biomedicines. 2023 Sep 29;11(10):2672. doi: 10.3390/biomedicines11102672. Biomedicines. 2023. PMID: 37893047 Free PMC article.
-
Follow-up of pre-motor symptoms of Parkinson's disease in adult patients with Gaucher disease type 1 and analysis of their lysosomal enzyme profiles in the CSF.Orphanet J Rare Dis. 2023 Oct 2;18(1):309. doi: 10.1186/s13023-023-02875-3. Orphanet J Rare Dis. 2023. PMID: 37784132 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
